It promotes angiogenesis, stromal remodeling and tumor invasion, and recruits Tregs and suppresses effector T cells by secreting TGF-β, IL-10, CCL2, etc., constructing an immunosuppressive microenvironment (42–51). Here, TGFB1 is linked to neoplasm.